When accessing the CDB site through an internal Novo Nordisk IP address, you will see "Your Location" as NN Internal instead of a country. This only applies to internal NN IP addresses. Thank you for your patience while the development team is upgrading this feature.

Your Location: USA

Help Join the Cause Submit Data

Bookmark and Share

Diabetes Complications

Overview

Diabetic complications can be grouped into two categories: acute and chronic...

More...

Strokes

A stroke occurs when the blood supply to part of the brain is interrupted and brain tissue is damaged...

More...

Amputations

The hyperglycaemia associated with diabetes can damage nerves in the feet, which can eventually lead to a loss of feeling...

More...

Heart Disease

Coronary artery disease, the most common form of coronary heart disease, is caused by fatty deposits narrowing or blocking the blood vessels that supply the heart...

More...

Hypoglycaemia

Hypoglycaemia is the term used to describe a state produced by a lower than normal level of blood glucose...

More...

Renal Failure

Millions of tiny blood vessels (capillaries) with even tinier holes in them act as filters in the kidneys...

More...

Vision Loss

Retinopathy is a complication of diabetes that can lead to blindness...

More...

Return To Top

See How Your Country Measures Up

Get diabetes data in four key areas: Quality of Care, Prevalence of Diabetes, Cost of Diabetes, and Access to Care

Diabetes Data

Join the Cause

Answer the call to measure, share, and improve

Join the Cause

Read About the Global Impact of Diabetes

Learn about the human and economic impact of diabetes in other countries

Briefing Books

References:
1. Fishbein H, Palumbo PJ. Acute metabolic complications in diabetes. In: Diabetes in AmericaI, 2nd Edition. National Diabetes Data Group, National Institutes of Health, National Insitute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 95-1468; 1995.
2. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676-1685.
3. American Diabetes Association. Standards of medical care in diabetes – 2011. Diabetes Care 2010; 34(Suppl 1): S11-S61.
4. Novo Nordisk. Changing Diabetes Barometer, First Report, 2007.
5. Stratton IM, Adler AI, Neil HA et al., for the United Kingdom Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258): 405-412.
6. Buse JB, Ginsberg HN, Bakris GL, Costa F, Eckel R, Fonseca V, et al. Primary prevention of cardiovascular disease in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2007;30:162-172.
7. Pearson et al. AHA guidelines for primary prevention of cardiovascular disease and stroke:2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106(3):388-391.
8. American Diabetes Association. Standards of medical care in diabetes – 2010. Diabetes Care 2010; 33(Suppl 1): S11-S61.
9. Centers for Disease Control and Prevention. National diabetes fact sheet, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
10. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetees Care. 2003;26:1903-1912.
11. UK Prospective Diabetes Study Group. UK prospective diabetes study 16: overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995;44(11): 1249-1258.
12. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837-853.
13. Maahs DM, Rewers M. Editorial: Mortality and renal disease in type 1 diabetes mellitus – progress made, more to be done. J Clin Endocrinol Metab. 2006;91(10):3757-3759.
14. American Diabetes Association. Nephropathy in diabetes (position statement). Diabetes Care 2004;27(Suppl 1):S79-S83.
15. Perneger TV, Brancati FL, Whelton PK, Klag MJ. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med. 1994;121(12):912-918.

Return To Top